This week’s newsletter covers fascinating research on fungal intelligence and decision-making, the ecological importance of flowers, CBD’s interactions with alcohol and its applications in dentistry and rheumatology, and psilocybin as a potential Alzheimer’s treatment.
Noteworthy Read
Fungi Can Learn and Make Decisions (Good News Network)
A recent study dives into how fungi exhibit signs of intelligence and adaptability, even without a brain. Researchers at Tohoku University found that mycelial networks can “decide” their growth direction based on environmental cues, showing purposeful behavior similar to basic cognition. Fungi communicate and adapt their growth to save resources, suggesting an intricate level of responsiveness more complex than previously understood. This research adds to our understanding of the intelligence potential in non-neural organisms and opens doors to learning more about communication and adaptability in ecosystems.
Read more
View more in Psychedelics
More Noteworthy Reading
Flowers and the Birth of Ecology (Nautilus)
This article reflects on how flowers reshaped life on Earth, transforming reproduction and driving the evolution of diverse ecosystems. Their appearance enabled complex relationships between plants and animals, leading to the emergence of fruit, warm-blooded mammals, and ultimately, humans.
Read more
View more in Endocannabinoid System
Is it safe to mix CBD & alcohol? (Medical News Today)
CBD, a non-psychoactive cannabis compound, may cause drowsiness similar to alcohol. Mixing the two could amplify sedation, but research on their combined effects is limited. CBD shows promise in reducing some harmful effects of alcohol on the liver and brain and may even help with alcohol use disorder by reducing alcohol intake.
Read more
View more in Drug Interactions
Research Round-Up
CBD in dentistry (PubMed)
CBD shows promise in dentistry due to its anti-inflammatory, pain-relieving, and antioxidant properties. This review highlights how CBD could help with various oral health conditions, though more research is needed to fully understand its effects and applications in dental care.
Psilocybin for treating Alzheimer’s (PubMed)
Alzheimer’s disease has limited treatments, spurring interest in psilocybin, known for helping with depression, as a potential option. This review explores its possible benefits, considerations for managing its hallucinogenic effects, and the ethical and legal challenges in using psilocybin as a treatment for Alzheimer’s.
Read more
View more in Psychedelics
CBD for rheumatological diseases (PubMed)
This review explores cannabis as a potential treatment for chronic pain and inflammation in rheumatic diseases such as fibromyalgia, osteoarthritis, rheumatoid arthritis, and others. Findings suggest cannabis could be a promising therapy for these conditions, warranting further research.
A heartfelt thank you to all of the CBD brands whose generous support powers Project CBD’s mission to bring you the latest in plant medicine research and journalism. We’re grateful for every partner who helps keep this important work going.
